Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STAR<i>net</i>)

• Main Authors: Katherine D. Mathews (Author), Kristin M. Conway (Author), Amber M. Gedlinske (Author), Nicholas Johnson (Author), Natalie Street (Author), Russell J. Butterfield (Author), Man Hung (Author), Emma Ciafaloni (Author), Paul A. Romitti (Author)
• Format: Book
• Published: MDPI AG, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Therapeutic trials are critical to improving outcomes for individuals diagnosed with Duchenne muscular dystrophy (DMD). Understanding predictors of clinical trial participation could maximize enrollment. Methods: Data from six sites (Colorado, Iowa, Piedmont region North Carolina, South...